Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biological-guided Metronomic Chemotherapy as Maintenance Strategy in Responders After Induction Therapy in Metastatic Colorectal Cancer

NCT03158610 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT03158610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03158610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biological-guided Metronomic Chemotherapy as Maintenance Strategy in Responders After Induction Therapy in Metastatic Colorectal Cancer
Lead sponsor
Ruijin Hospital
Phase
Phase 2/3
Overall status
Terminated
Start date
January 29, 2018
Completion date
April 28, 2021
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer